메뉴 건너뛰기




Volumn 30, Issue 2, 2007, Pages 155-160

Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration;Traitement simultané par photothérapie dynamique et triamcinolone intravitréenne des néovaisseaux associés à un décollement de l'épithélium pigmentaire

Author keywords

Age related macular degeneration; Pigment epithelium detachment; Triamcinolone acetonide

Indexed keywords


EID: 33847333274     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0181-5512(07)89566-0     Document Type: Article
Times cited : (5)

References (21)
  • 1
    • 0342632445 scopus 로고    scopus 로고
    • Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials - TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group
    • Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group
    • Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol, 1999;117:1329-45.
    • (1999) Arch Ophthalmol , vol.117 , pp. 1329-1345
  • 2
    • 0035009086 scopus 로고    scopus 로고
    • Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy
    • Vertepofin In Photodynamic Therapy Study Group
    • Vertepofin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy report 2. Am J Ophthalmol, 2001;131:541-60.
    • (2001) Am J Ophthalmol , vol.131 , pp. 541-560
  • 3
    • 28444457478 scopus 로고    scopus 로고
    • Anaphylactoid reaction after verteporfin therapy
    • Doshi AB, Moshfeghi DM, Jack RL. Anaphylactoid reaction after verteporfin therapy. Am J Ophthalmol, 2005;140:936-7.
    • (2005) Am J Ophthalmol , vol.140 , pp. 936-937
    • Doshi, A.B.1    Moshfeghi, D.M.2    Jack, R.L.3
  • 4
    • 1842556553 scopus 로고    scopus 로고
    • Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: Case reports from randomized clinical trials-TAP and VIP report no. 3
    • Arnold JJ, Blinder KJ, Bressler NM, Bressler SB, Burdan A, Haynes L, et al. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3. Am J Ophthalmol, 2004;137:683-96.
    • (2004) Am J Ophthalmol , vol.137 , pp. 683-696
    • Arnold, J.J.1    Blinder, K.J.2    Bressler, N.M.3    Bressler, S.B.4    Burdan, A.5    Haynes, L.6
  • 5
    • 21044453724 scopus 로고    scopus 로고
    • A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration
    • Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA, 2005;102:7227-32.
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 7227-7232
    • Hageman, G.S.1    Anderson, D.H.2    Johnson, L.V.3    Hancox, L.S.4    Taiber, A.J.5    Hardisty, L.I.6
  • 6
    • 29644437763 scopus 로고    scopus 로고
    • Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration
    • Augustin AJ, Schmidt-Erfurth U. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Ophthalmology, 2006;113:14-22.
    • (2006) Ophthalmology , vol.113 , pp. 14-22
    • Augustin, A.J.1    Schmidt-Erfurth, U.2
  • 8
    • 18844420246 scopus 로고    scopus 로고
    • Verteporfin therapy in combination with triamcinolone: Published studies investigating a potential synergistic effect
    • Kaiser PK. Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effect. Curr Med Res Opin, 2005;21:705-13.
    • (2005) Curr Med Res Opin , vol.21 , pp. 705-713
    • Kaiser, P.K.1
  • 9
    • 1542317855 scopus 로고    scopus 로고
    • Safety of an intravitreal injection of triamcinolone: Results from a randomized clinical trial
    • Gillies MC, Simpson JM, Billson FA, Luo W, Penfold P, Chua W, et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol, 2004;122:336-40.
    • (2004) Arch Ophthalmol , vol.122 , pp. 336-340
    • Gillies, M.C.1    Simpson, J.M.2    Billson, F.A.3    Luo, W.4    Penfold, P.5    Chua, W.6
  • 11
    • 24344487980 scopus 로고    scopus 로고
    • Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization
    • Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization. Retina, 2005;25:685-90.
    • (2005) Retina , vol.25 , pp. 685-690
    • Spaide, R.F.1    Sorenson, J.2    Maranan, L.3
  • 12
    • 1542407176 scopus 로고    scopus 로고
    • Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration
    • Rechtman E, Danis RP, Pratt LM, Harris A. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol, 2004;88:344-7.
    • (2004) Br J Ophthalmol , vol.88 , pp. 344-347
    • Rechtman, E.1    Danis, R.P.2    Pratt, L.M.3    Harris, A.4
  • 13
    • 0042029477 scopus 로고    scopus 로고
    • Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization
    • Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology, 2003;110:1517-25.
    • (2003) Ophthalmology , vol.110 , pp. 1517-1525
    • Spaide, R.F.1    Sorenson, J.2    Maranan, L.3
  • 14
    • 33644639309 scopus 로고    scopus 로고
    • Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: A comparative study
    • Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study. Br J Ophthalmol, 2006;90:337-41.
    • (2006) Br J Ophthalmol , vol.90 , pp. 337-341
    • Chan, W.M.1    Lai, T.Y.2    Wong, A.L.3    Tong, J.P.4    Liu, D.T.5    Lam, D.S.6
  • 16
    • 0033944912 scopus 로고    scopus 로고
    • Intravitreal triamcinolone acetonide in exudative age-related macular degeneration
    • Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina, 2000;20:244-50.
    • (2000) Retina , vol.20 , pp. 244-250
    • Danis, R.P.1    Ciulla, T.A.2    Pratt, L.M.3    Anliker, W.4
  • 17
    • 0842283900 scopus 로고    scopus 로고
    • Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration
    • Jonas JB, Akkoyun I, Budde WM, Kreissig I, Degenring RF. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration. Arch Ophthalmol, 2004;122:218-22.
    • (2004) Arch Ophthalmol , vol.122 , pp. 218-222
    • Jonas, J.B.1    Akkoyun, I.2    Budde, W.M.3    Kreissig, I.4    Degenring, R.F.5
  • 19
    • 0025776268 scopus 로고
    • Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study
    • Macular Photocoagulation Study Group
    • Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol, 1991;109:1242-57.
    • (1991) Arch Ophthalmol , vol.109 , pp. 1242-1257
  • 20
    • 1842530300 scopus 로고    scopus 로고
    • Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration
    • Axer-Siegel R, Ehrlich R, Rosenblatt I, Kramer M, Priel E, Yassur Y, et al. Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration. Arch Ophthalmol, 2004;122:453-9.
    • (2004) Arch Ophthalmol , vol.122 , pp. 453-459
    • Axer-Siegel, R.1    Ehrlich, R.2    Rosenblatt, I.3    Kramer, M.4    Priel, E.5    Yassur, Y.6
  • 21
    • 31944437168 scopus 로고    scopus 로고
    • Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone
    • Michels S, Aue A, Simader C, Geitzenauer W, Sacu S, Schmidt-Erfurth U. Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone. Am J Ophthalmol, 2006;141:396-8.
    • (2006) Am J Ophthalmol , vol.141 , pp. 396-398
    • Michels, S.1    Aue, A.2    Simader, C.3    Geitzenauer, W.4    Sacu, S.5    Schmidt-Erfurth, U.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.